Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2024

Open Access 01-04-2024 | Thrush | Research

Analysis of Clinical, Immunological and Molecular Features of Leukocyte Adhesion Deficiency Type I in Egyptian Children

Authors: Mai Magdy Saad, Radwa Alkady, Alia Eldash, Rabab E. El Hawary, Safa S. Meshaal, Nermeen M. Galal, Aisha M. Elmarsafy

Published in: Journal of Clinical Immunology | Issue 4/2024

Login to get access

Abstract

Purpose

Leukocyte adhesion deficiency (LAD) represents a rare group of inherited inborn errors of immunity (IEI) characterized by bacterial infections, delayed umbilical stump separation, and autoimmunity. This single-center study aimed at describing the clinical, immunological, and molecular characterizations of 34 LAD-I Egyptian pediatric patients.

Methods

Details of 34 patients’ personal medical history, clinical and laboratory findings were recorded; Genetic material from 28 patients was studied. Mutational analysis was done by Sanger sequencing.

Results

Omphalitis, skin and soft tissue infections with poorly healing ulcers, delayed falling of the umbilical stump, and recurrent or un-resolving pneumonia were the most common presentations, followed by chronic otitis media, enteropathy, periodontitis; and recurrent oral thrush. Persistent leukocytosis and neutrophilia were reported in all patients, as well as CD18 and CD11b deficiency. CD18 expression was < 2% in around 90% of patients. Sixteen different pathological gene variants were detected in 28 patients who underwent ITGß2 gene sequencing, of those, ten were novel and six were previously reported. Three families received a prenatal diagnosis. Patients were on antimicrobials according to culture’s results whenever available, and on prophylactic Trimethoprim-Sulfamethoxazole 5 mg/kg once daily, with regular clinical follow up. Hematopoietic stem cell transplantation (HSCT) was offered for 4 patients. However due to severity of the disease and delay in diagnosis, 58% of the patients passed away in the first 2 years of life.

Conclusion

This study highlights the importance of early diagnosis and distribution of ITGß2 gene mutation in Egyptian children. Further molecular studies, however, remain a challenging necessity for better disease characterization in the region.
Literature
1.
go back to reference Bouhouche A, Tabache Y, Askander O, Charoute H, Mesnaoui N, Belayachi L et al. Novel ITGB2 mutation is responsible for a severe form of Leucocyte Adhesion Deficiency Type 1. Biomed Res Int. 2022;2022. Bouhouche A, Tabache Y, Askander O, Charoute H, Mesnaoui N, Belayachi L et al. Novel ITGB2 mutation is responsible for a severe form of Leucocyte Adhesion Deficiency Type 1. Biomed Res Int. 2022;2022.
2.
go back to reference Das J, Sharma A, Jindal A, Aggarwal V, Rawat A. Leukocyte adhesion defect: where do we stand Circa 2019? Chongqing Univ. 2020;7(1):107–14. Genes and Diseases. Das J, Sharma A, Jindal A, Aggarwal V, Rawat A. Leukocyte adhesion defect: where do we stand Circa 2019? Chongqing Univ. 2020;7(1):107–14. Genes and Diseases.
3.
go back to reference Kambli PM, Bargir UA, Yadav RM, Gupta MR, Dalvi AD, Hule G, et al. Clinical and genetic spectrum of a large cohort of patients with leukocyte Adhesion Deficiency Type 1 and 3: a Multicentric Study from India. Front Immunol. 2020;11:612703.CrossRefPubMedPubMedCentral Kambli PM, Bargir UA, Yadav RM, Gupta MR, Dalvi AD, Hule G, et al. Clinical and genetic spectrum of a large cohort of patients with leukocyte Adhesion Deficiency Type 1 and 3: a Multicentric Study from India. Front Immunol. 2020;11:612703.CrossRefPubMedPubMedCentral
4.
go back to reference Bakhtiar S, Salzmann-Manrique E, Blok HJ, Eikema DJ, Hazelaar S, Ayas M, et al. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III. Blood Adv. 2021;5(1):262–73.PubMedPubMedCentral Bakhtiar S, Salzmann-Manrique E, Blok HJ, Eikema DJ, Hazelaar S, Ayas M, et al. Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III. Blood Adv. 2021;5(1):262–73.PubMedPubMedCentral
5.
go back to reference Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.CrossRefPubMed Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20.CrossRefPubMed
6.
go back to reference Meshaal S, El Hawary R, Eldash A, Erfan A, Abd Elaziz D, Alkady R, et al. Flow cytometry optimizing the diagnostic approach in inborn errors of immunity: experience from Egypt. Allergy Asthma Clin Immunol. 2022;18(1):45. Meshaal S, El Hawary R, Eldash A, Erfan A, Abd Elaziz D, Alkady R, et al. Flow cytometry optimizing the diagnostic approach in inborn errors of immunity: experience from Egypt. Allergy Asthma Clin Immunol. 2022;18(1):45.
7.
go back to reference Yassaee VR, Hashemi-Gorji F, Boosaliki S, Parvaneh N. Mutation spectra of the ITGB2 gene in Iranian families with leukocyte adhesion deficiency type 1. Hum Immunol. 2016;77(2):191–5.CrossRefPubMed Yassaee VR, Hashemi-Gorji F, Boosaliki S, Parvaneh N. Mutation spectra of the ITGB2 gene in Iranian families with leukocyte adhesion deficiency type 1. Hum Immunol. 2016;77(2):191–5.CrossRefPubMed
8.
go back to reference Mortezaee FT, Esmaeli B, Badalzadeh M, Ghadami M, Fazlollahi MR, Alizade Z, et al. Investigation of ITGB2 gene in 12 new cases of leukocyte adhesion deficiency-type I revealed four novel mutations from Iran. Arch Iran Med. 2015;18(11):760–4. Mortezaee FT, Esmaeli B, Badalzadeh M, Ghadami M, Fazlollahi MR, Alizade Z, et al. Investigation of ITGB2 gene in 12 new cases of leukocyte adhesion deficiency-type I revealed four novel mutations from Iran. Arch Iran Med. 2015;18(11):760–4.
9.
go back to reference Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, et al. Performance of ACMG-AMP variant-interpretation guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016;98(6):1067–76.CrossRefPubMedPubMedCentral Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, et al. Performance of ACMG-AMP variant-interpretation guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet. 2016;98(6):1067–76.CrossRefPubMedPubMedCentral
10.
go back to reference EL Hawary RE, Meshaal SS, Abd Elaziz SS, Alkady DS, Lotfy R, Eldash S. Genetic testing in Egyptian patients with inborn errors of immunity: a single-center experience. J Clin Immunol. 2022;42(5):1051–70. EL Hawary RE, Meshaal SS, Abd Elaziz SS, Alkady DS, Lotfy R, Eldash S. Genetic testing in Egyptian patients with inborn errors of immunity: a single-center experience. J Clin Immunol. 2022;42(5):1051–70.
11.
go back to reference EL Hawary RE, Meshaal SS, Abd Elaziz DS, Elsharkawy MA, Alkady RS, Lotfy S, et al. Genetic counseling in primary immunodeficiency disorders: an emerging experience in Egypt. Mol Diagn Ther. 2017;21(6):677–84. EL Hawary RE, Meshaal SS, Abd Elaziz DS, Elsharkawy MA, Alkady RS, Lotfy S, et al. Genetic counseling in primary immunodeficiency disorders: an emerging experience in Egypt. Mol Diagn Ther. 2017;21(6):677–84.
12.
go back to reference Wolach B, Gavrieli R, Wolach O, Stauber T, Abuzaitoun O, Kuperman A, et al. Leucocyte adhesion deficiency-A multicentre national experience. Eur J Clin Invest. 2019;49(2):e13047.CrossRefPubMed Wolach B, Gavrieli R, Wolach O, Stauber T, Abuzaitoun O, Kuperman A, et al. Leucocyte adhesion deficiency-A multicentre national experience. Eur J Clin Invest. 2019;49(2):e13047.CrossRefPubMed
13.
go back to reference Nawaz Tipu H, Raza R, Jaffar S, Khan A, Anwar MZ, Ahmad W et al. β2 integrin gene (ITGB2) mutation spectra in Pakistani families with leukocyte adhesion deficiency type 1 (LAD1). Immunobiology. 2020;225(3). Nawaz Tipu H, Raza R, Jaffar S, Khan A, Anwar MZ, Ahmad W et al. β2 integrin gene (ITGB2) mutation spectra in Pakistani families with leukocyte adhesion deficiency type 1 (LAD1). Immunobiology. 2020;225(3).
14.
go back to reference Celiksoy MH, Köker MY, Gezdirici A, Ozsoy S, Malbora B, Gungor S. A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I. Immunol Res. 2021;69(5):461–6.CrossRefPubMed Celiksoy MH, Köker MY, Gezdirici A, Ozsoy S, Malbora B, Gungor S. A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I. Immunol Res. 2021;69(5):461–6.CrossRefPubMed
15.
go back to reference Yaz I, Ozbek B, Bildik HN, Tan C, Oskay Halacli S, Soyak Aytekin E, et al. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: a multicenter study in Turkey. Clin Exp Immunol. 2021Oct;206(1):47–55. Yaz I, Ozbek B, Bildik HN, Tan C, Oskay Halacli S, Soyak Aytekin E, et al. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: a multicenter study in Turkey. Clin Exp Immunol. 2021Oct;206(1):47–55.
17.
go back to reference Suksawat Y, Pacharn P, Siripipattanamongkol N, Boonyawat B. Three novel homozygous ITGB2 mutations among two patients with leukocyte adhesion defect type-1: two case reports. World J Clin Pediatr. 2022;11(5):429.CrossRefPubMedPubMedCentral Suksawat Y, Pacharn P, Siripipattanamongkol N, Boonyawat B. Three novel homozygous ITGB2 mutations among two patients with leukocyte adhesion defect type-1: two case reports. World J Clin Pediatr. 2022;11(5):429.CrossRefPubMedPubMedCentral
18.
go back to reference Iyengar VV, Taur P, Gowri V, Chougule A, Kambli P, Madkaikar M, et al. Leukocyte adhesion defect: clinical correlation with integrin expression and genetics. Wadia J Women Child Health. 2022;1(1):3–7.CrossRef Iyengar VV, Taur P, Gowri V, Chougule A, Kambli P, Madkaikar M, et al. Leukocyte adhesion defect: clinical correlation with integrin expression and genetics. Wadia J Women Child Health. 2022;1(1):3–7.CrossRef
19.
go back to reference De Rose DU, Giliani S, Notarangelo LD, Lougaris V, Lanfranchi A, Moratto D, et al. Long term outcome of eight patients with type 1 leukocyte Adhesion Deficiency (LAD-1): not only infections, but high risk of autoimmune complications. Clin Immunol. 2018;191:75–80.CrossRefPubMed De Rose DU, Giliani S, Notarangelo LD, Lougaris V, Lanfranchi A, Moratto D, et al. Long term outcome of eight patients with type 1 leukocyte Adhesion Deficiency (LAD-1): not only infections, but high risk of autoimmune complications. Clin Immunol. 2018;191:75–80.CrossRefPubMed
20.
go back to reference Madkaikar M, Italia K, Gupta M, Desai M, Aggarwal A, Singh S, et al. Leukocyte Adhesion Deficiency-I with a Novel Intronic Mutation presenting with Pyoderma Gangrenosum- Like Lesions. J Clin Immunol. 2015;35(4):431–4.CrossRefPubMed Madkaikar M, Italia K, Gupta M, Desai M, Aggarwal A, Singh S, et al. Leukocyte Adhesion Deficiency-I with a Novel Intronic Mutation presenting with Pyoderma Gangrenosum- Like Lesions. J Clin Immunol. 2015;35(4):431–4.CrossRefPubMed
21.
go back to reference Thakur N, Sodani R, Chandra J, Singh V. Leukocyte adhesion defect type 1 presenting with recurrent pyoderma gangrenosum. Indian J Dermatol. 2013;58(2):158.CrossRefPubMedPubMedCentral Thakur N, Sodani R, Chandra J, Singh V. Leukocyte adhesion defect type 1 presenting with recurrent pyoderma gangrenosum. Indian J Dermatol. 2013;58(2):158.CrossRefPubMedPubMedCentral
22.
go back to reference Opalińska A, Burdacki A, Kwaśniak K, Pogoda K, Tabarkiewicz J, Reich A. Pyoderma Gangrenosum with an underlying leukocyte Adhesion Deficiency Type 1 (LAD-1) and pregnancy in the Shade of COVID-19 epidemic: a patient and physician experience. Dermatol Ther (Heidelb). 2021;11(3):643.CrossRefPubMed Opalińska A, Burdacki A, Kwaśniak K, Pogoda K, Tabarkiewicz J, Reich A. Pyoderma Gangrenosum with an underlying leukocyte Adhesion Deficiency Type 1 (LAD-1) and pregnancy in the Shade of COVID-19 epidemic: a patient and physician experience. Dermatol Ther (Heidelb). 2021;11(3):643.CrossRefPubMed
23.
go back to reference Madkaikar M, Italia K, Gupta M, Chavan S, Mishra A, Rao M et al. Blood cells, molecules and diseases Molecular characterization of leukocyte adhesion deficiency-I in Indian patients : identification of 9 novel mutations. 2015;54:217–23. Madkaikar M, Italia K, Gupta M, Chavan S, Mishra A, Rao M et al. Blood cells, molecules and diseases Molecular characterization of leukocyte adhesion deficiency-I in Indian patients : identification of 9 novel mutations. 2015;54:217–23.
24.
go back to reference Silva LM, Brenchley L, Moutsopoulos NM. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis. Immunolo Rev. 2019;287(1):226–35. Silva LM, Brenchley L, Moutsopoulos NM. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis. Immunolo Rev. 2019;287(1):226–35.
25.
go back to reference Hajishengallis G, Moutsopoulos NM. Etiology of leukocyte adhesion deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response. Expert Rev Clin Immunol. 2014;10(8):973–5.CrossRefPubMedPubMedCentral Hajishengallis G, Moutsopoulos NM. Etiology of leukocyte adhesion deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response. Expert Rev Clin Immunol. 2014;10(8):973–5.CrossRefPubMedPubMedCentral
26.
go back to reference Moutsopoulos NM, Zerbe CS, Wild T, Dutzan N, Brenchley L, DiPasquale G, et al. Interleukin-12 and Interleukin-23 blockade in Leukocyte Adhesion Deficiency Type 1. N Engl J Med. 2017;376(12):1141–6.CrossRefPubMedPubMedCentral Moutsopoulos NM, Zerbe CS, Wild T, Dutzan N, Brenchley L, DiPasquale G, et al. Interleukin-12 and Interleukin-23 blockade in Leukocyte Adhesion Deficiency Type 1. N Engl J Med. 2017;376(12):1141–6.CrossRefPubMedPubMedCentral
27.
go back to reference Anis S, Abid A, Kodwavwala SAU, Sarfaraz S, Junejo S, Shahid S, et al. Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation. Allergy Asthma Clin Immunol. 2023;19(1):1–8.CrossRef Anis S, Abid A, Kodwavwala SAU, Sarfaraz S, Junejo S, Shahid S, et al. Rare and heterogeneous manifestations of leucocyte adhesion deficiency type 1: report of two cases with diagnostic dilemmas and novel ITGB2 mutation. Allergy Asthma Clin Immunol. 2023;19(1):1–8.CrossRef
28.
go back to reference Sun B, Chen Q, Dong X, Liu D, Hou J, Wang W, et al. Report of a Chinese cohort with Leukocyte Adhesion Deficiency-I and four novel mutations. J Clin Immunol. 2019;39(3):309–15.CrossRefPubMed Sun B, Chen Q, Dong X, Liu D, Hou J, Wang W, et al. Report of a Chinese cohort with Leukocyte Adhesion Deficiency-I and four novel mutations. J Clin Immunol. 2019;39(3):309–15.CrossRefPubMed
29.
go back to reference Haynes A, O’Keefe A, Dancey P, Ohson K, Turner L, Chard M. Leukocyte adhesion deficiency-I caused by a novel mutation in ITGB2 presenting with pyoderma gangrenosum.2018;5(3):86–90. Haynes A, O’Keefe A, Dancey P, Ohson K, Turner L, Chard M. Leukocyte adhesion deficiency-I caused by a novel mutation in ITGB2 presenting with pyoderma gangrenosum.2018;5(3):86–90.
30.
go back to reference Raza R, Khalid Z, Zaman A, Jafar S, Anwar MZ, Hassan SW et al. Sequence variants in the ITGB2 gene underlying leukocyte adhesion deficiency Type-1 in four consanguineous families. Gene Rep. 2022;29. Raza R, Khalid Z, Zaman A, Jafar S, Anwar MZ, Hassan SW et al. Sequence variants in the ITGB2 gene underlying leukocyte adhesion deficiency Type-1 in four consanguineous families. Gene Rep. 2022;29.
31.
go back to reference Geroldinger-Simić M, Lehner K, Klein G, Sepp N, Jabkowski J. An adult with severe leukocyte adhesion deficiency type 1. JAAD Case Rep. 2022;19:1–3.CrossRefPubMed Geroldinger-Simić M, Lehner K, Klein G, Sepp N, Jabkowski J. An adult with severe leukocyte adhesion deficiency type 1. JAAD Case Rep. 2022;19:1–3.CrossRefPubMed
32.
go back to reference Almarza Novoa E, Kasbekar S, Thrasher AJ, Kohn DB, Sevilla J, Nguyen T, et al. Leukocyte adhesion deficiency-I: a comprehensive review of all published cases. J Allergy Clin Immunology: Pract. 2018;6(4):1418–e142010. Almarza Novoa E, Kasbekar S, Thrasher AJ, Kohn DB, Sevilla J, Nguyen T, et al. Leukocyte adhesion deficiency-I: a comprehensive review of all published cases. J Allergy Clin Immunology: Pract. 2018;6(4):1418–e142010.
33.
go back to reference Hu J, Zhang Q, Zheng H, Chang H, Xian Y, Nie N, et al. Novel mutations in the β2 integrin gene (ITGB2) in a moderate leukocyte adhesion defect type 1 patient. Arch Iran Med. 2018;21(7):296–301.PubMed Hu J, Zhang Q, Zheng H, Chang H, Xian Y, Nie N, et al. Novel mutations in the β2 integrin gene (ITGB2) in a moderate leukocyte adhesion defect type 1 patient. Arch Iran Med. 2018;21(7):296–301.PubMed
34.
go back to reference El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, et al. Role of Flow Cytometry in the diagnosis of chronic Granulomatous Disease: the Egyptian experience. J Clin Immunol. 2016;36(6):610–8.CrossRefPubMed El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, et al. Role of Flow Cytometry in the diagnosis of chronic Granulomatous Disease: the Egyptian experience. J Clin Immunol. 2016;36(6):610–8.CrossRefPubMed
35.
go back to reference Roos D, van Leeuwen K, Madkaikar M, Kambli PM, Gupta M, Mathews V, et al. Hematologically important mutations: leukocyte adhesion deficiency (second update). Blood Cells Mol Dis. 2023;99:102726.CrossRefPubMed Roos D, van Leeuwen K, Madkaikar M, Kambli PM, Gupta M, Mathews V, et al. Hematologically important mutations: leukocyte adhesion deficiency (second update). Blood Cells Mol Dis. 2023;99:102726.CrossRefPubMed
37.
go back to reference Van De Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48(1):53–61. Van De Vijver E, Maddalena A, Sanal Ö, Holland SM, Uzel G, Madkaikar M, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48(1):53–61.
Metadata
Title
Analysis of Clinical, Immunological and Molecular Features of Leukocyte Adhesion Deficiency Type I in Egyptian Children
Authors
Mai Magdy Saad
Radwa Alkady
Alia Eldash
Rabab E. El Hawary
Safa S. Meshaal
Nermeen M. Galal
Aisha M. Elmarsafy
Publication date
01-04-2024
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2024
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-024-01693-x

Other articles of this Issue 4/2024

Journal of Clinical Immunology 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine